Indication & Dosage :
Semaglo (Semaglutide), generic OZEMPIC is a prescription medicine used to treat type 2 diabetes mellitus with improving glycemic control in patients and to reduce the risk of major adverse cardiovascular events in patients with type 2 diabetes mellitus and established cardiovascular disease. Semaglo is manufactured by Ziska Pharma Ltd. in Bangladesh.
Semaglutide has to take orally (no more than 4 ounces or 120 milliliters) usually once daily with or without food.
Side Effects :
The most common adverse reactions of Semaglutide are:
Nausea, vomiting, abdominal pain, loss of appetite, diarrhea, or constipation
The above information comes from the Internet. Please consult with doctor for medical advice.
Suggestion :
* Any advice on the use of the drug is for reference only. Please consult with doctor for medical advice. All Names, logos, and trademarks are property of their respective owners. Watermarks, QR code used for identification purposes only.
*Semaglutide can be used as long as the product has not been exposed to temperatures below 36°F or above 86°F. If Semaglutide was exposed to non-refrigerated temperatures (any temperature above 46ºF), the product must be used or discarded within 56 days. (Reference by: https://www.scientific-exchange.com/product-information/storage-and-stability/glp-1-ras.html).
